Bank of New York Mellon’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-14,721
| Closed | -$19K | – | 4490 |
|
|
2017
Q4 | $19K | Sell |
14,721
-1
| -0% | -$1 | ﹤0.01% | 4289 |
|
|
2017
Q3 | $31K | Buy |
14,722
+1
| +0% | +$2 | ﹤0.01% | 4177 |
|
|
2017
Q2 | $43K | Sell |
14,721
-4,275
| -23% | -$12.5K | ﹤0.01% | 4153 |
|
|
2017
Q1 | $66K | Buy |
18,996
+4,002
| +27% | +$13.9K | ﹤0.01% | 4098 |
|
|
2016
Q4 | $26K | Sell |
14,994
-691
| -4% | -$1.2K | ﹤0.01% | 4195 |
|
|
2016
Q3 | $52K | Sell |
15,685
-2,764
| -15% | -$9.16K | ﹤0.01% | 4132 |
|
|
2016
Q2 | $79K | Sell |
18,449
-38,276
| -67% | -$164K | ﹤0.01% | 4102 |
|
|
2016
Q1 | $320K | Buy |
56,725
+208
| +0.4% | +$1.17K | ﹤0.01% | 3622 |
|
|
2015
Q4 | $972K | Buy |
56,517
+4,040
| +8% | +$69.5K | ﹤0.01% | 3176 |
|
|
2015
Q3 | $1.11M | Sell |
52,477
-21,509
| -29% | -$454K | ﹤0.01% | 3098 |
|
|
2015
Q2 | $3.66M | Sell |
73,986
-5,444
| -7% | -$269K | ﹤0.01% | 2553 |
|
|
2015
Q1 | $6.22M | Buy |
79,430
+2,701
| +4% | +$211K | ﹤0.01% | 2197 |
|
|
2014
Q4 | $4.65M | Buy |
76,729
+2,167
| +3% | +$131K | ﹤0.01% | 2348 |
|
|
2014
Q3 | $3.18M | Buy |
74,562
+8,809
| +13% | +$375K | ﹤0.01% | 2577 |
|
|
2014
Q2 | $4.06M | Buy |
65,753
+7,650
| +13% | +$473K | ﹤0.01% | 2438 |
|
|
2014
Q1 | $3.78M | Buy |
58,103
+8,801
| +18% | +$572K | ﹤0.01% | 2459 |
|
|
2013
Q4 | $2.78M | Sell |
49,302
-7,700
| -14% | -$434K | ﹤0.01% | 2669 |
|
|
2013
Q3 | $3.49M | Buy |
57,002
+7,885
| +16% | +$483K | ﹤0.01% | 2468 |
|
|
2013
Q2 | $2.87M | Buy |
+49,117
| New | +$2.87M | ﹤0.01% | 2550 |
|